您的位置: 首页 > 农业专利 > 详情页

MODULATION OF THE IMMUNE RESPONSE
专利权人:
THE BRIGHAM AND WOMEN'S HOSPITAL; INC.
发明人:
RICHARD S. BLUMBERG,VIJAY K. KUCHROO,YU-HWA HUANG,CHEN ZHU,ANA C. ANDERSON
申请号:
US16676036
公开号:
US20200095284A1
申请日:
2019.11.06
申请国别(地区):
US
年份:
2020
代理人:
摘要:
Described herein are compositions and methods for the modulation of T-cell tolerance, which can be upregulated or down regulated by concurrent enhancement or inhibition of CEACAM1/TIM3 interactions. As described herein, the discovery that CEACAM1 is a direct ligand of TIM3 and vice versa has been shown in cis and in trans. In addition, as demonstrated herein, CEACAM1 and TIM3 are co-regulated during the course of T-cell activation.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充